Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in anesthesia for kidney transplantation
ChiCTR1800019433Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in kidney failure (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoints: Blood urea nitrogen, Estimated glomerular filtration rate and 4 more. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
kidney failure
Beyond the preview
Go deeper on ChiCTR1800019433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019433.